A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/19/2011	EP2377545A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
10/19/2011	EP2377544A2 Pharmaceutical composition containing angiotensin-(1-9) for cardiovascular, pulmonary and/or cerebral treatment
10/19/2011	EP2377532A1 Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists for treating dermatological disorders
10/19/2011	EP2377519A2 Pharmaceutical Composition Comprising Octreotide Microparticles
10/19/2011	EP2376531A1 Novel insulin analogues
10/19/2011	EP2376530A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376529A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same
10/19/2011	EP2376524A1 Derivatives of cyclosporin a
10/19/2011	EP2376522A2 Low viscosity highly concentrated suspensions
10/19/2011	EP2376520A1 Insulin analogs
10/19/2011	EP2376494A1 Dihydropyrimidopyrimidine derivatives
10/19/2011	EP2376117A1 Hepatitis c virus combination therapy
10/19/2011	EP2376106A1 Bone grafts with reduced protease activity and methods of selection and use
10/19/2011	EP2376105A1 Nkg2d-fc for immunotherapy
10/19/2011	EP2376104A1 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/19/2011	EP2376103A1 Cyclosporine compositions for enhancing nail growth
10/19/2011	EP2376102A1 Compositions for enhancing nail growth
10/19/2011	EP2376101A2 ß-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
10/19/2011	EP2376100A2 Peptidomimetic macrocycles
10/19/2011	EP2376099A1 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
10/19/2011	EP2376098A1 Dipeptide linked medicinal agents
10/19/2011	EP2376097A1 Amide based glucagon superfamily peptide prodrugs
10/19/2011	EP2376096A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
10/19/2011	EP2376090A1 Inhibition of apoe cleavage activity in the treatment of apoe-related disorders
10/19/2011	EP2376078A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
10/19/2011	EP2376063A1 Novel form of administering osteogenic protein complexes
10/19/2011	EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses
10/19/2011	EP2363142A9 Elastase for opening obstructed biological conduits
10/19/2011	EP2101809B1 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction
10/19/2011	EP1993587B1 Use of the engrailed homeodomain protein as an anxiolytic
10/19/2011	EP1807517B1 Bacterial vector
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1651161B1 Pharmaceutical compositions and methods for accelerating wound healing
10/19/2011	EP1633391B1 Stabilized pharmaceutical peptide compositions
10/19/2011	EP1622597B1 Modulation of apolipoprotein c-iii expression
10/19/2011	EP1572918B1 Synthetic glyco-lipo-peptides as vaccines
10/19/2011	EP1563308B1 Methods and kits for diagnosing tumorigenicity
10/19/2011	EP1383793B1 Insulin and igf-1 receptor agonists and antagonists
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
10/19/2011	CN1973037B Process for producing dipeptides or dipeptide derivatives
10/19/2011	CN1964627B Methods and compositions for treating neuropathies
10/19/2011	CN1938332B Inhibitors of serine proteases, particularly HCV NS3-HS4A protease
10/19/2011	CN1867669B Method for producing gamma-carboxylated proteins
10/19/2011	CN102224170A Materials and methods for inhibiting cancer cell invasion related to fgfr4
10/19/2011	CN102224167A Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
10/19/2011	CN102224164A Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
10/19/2011	CN102224163A Anti-apoptotic fusion proteins
10/19/2011	CN102224161A Antiinflammatory peptide
10/19/2011	CN102223915A New therapy and medicament using integrin ligands for treating cancer
10/19/2011	CN102223898A Peptides for treatment of obesity
10/19/2011	CN102223893A Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis
10/19/2011	CN102223892A Compounds and methods for the treatment of vascular disease
10/19/2011	CN102223891A Peptidomimetic macrocycles with improved properties
10/19/2011	CN102223890A Process for the synthesis of (aib8,35)hglp-1(7-36)-nh2
10/19/2011	CN102220362A Technique for constructing bait alga capable of effectively expressing antibacterial peptide and application method
10/19/2011	CN102220298A Ferulic acid esterase FaeI as well as coding gene and application thereof
10/19/2011	CN102220256A Yeast expression system for expressing HAS-Vmip-II fusion protein and construction method thereof
10/19/2011	CN102220255A Recombinant antimicrobial peptide (AMP) as well as genetic engineering preparation method and application thereof
10/19/2011	CN102219860A FGFR-Fc fusion protein and applications thereof
10/19/2011	CN102219859A Fusion protein for antagonizing angiogenesis inducible factor and application thereof
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102219847A Defensin mNP-1 and applications thereof in preparing anti-influenza virus drugs
10/19/2011	CN102219835A Long peptide based on HCA587 antigen and its application in preparing antitumor drugs
10/19/2011	CN102219831A Antibiotic peptide as well as preparation method and application thereof
10/19/2011	CN102218135A Application of alpha2-3 neuraminidase in induction of transplantation immune tolerance
10/19/2011	CN102218134A L-arginine-glucose-insulin-potassium chloride composition and application thereof
10/19/2011	CN102218133A Injection oxytocin for loach
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101785782B Long-circulating ligustrazine composite injection and preparation method thereof
10/19/2011	CN101756912B Hemocoagulase freeze-dried powder injection and preparation method thereof
10/19/2011	CN101480491B Bone collagen polypeptide composite solution for regulating intestines and preparation method thereof
10/19/2011	CN101280012B Exendin-4 active isomer and application thereof
10/18/2011	US8039623 Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus
10/18/2011	US8039591 Flowable collagen material for dural closure
10/18/2011	US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039584 Carbon nanotube binding peptides
10/18/2011	US8039583 Carbon nanotube binding peptides
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039505 Compounds for modulating T-cells
10/18/2011	US8039448 N-acylated chitinous polymers and methods of use thereof
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039443 polynucleotides that bind to proteins that regulate cell growth and division; used as antitumor agents alone or in combination with known cytotoxic agents
10/18/2011	US8039440 Peptides for inhibiting chemokine binding to chemokine receptors
10/18/2011	US8039439 Cellular cycle anomalies for targeting oncology and neurodegeneration
10/18/2011	US8039438 Amino acid sequences for use in treatment and prevention of cell proliferative disorders; antitumor agents
10/18/2011	US8039437 Fn14/TRAIL fusion proteins
10/18/2011	US8039436 Mutated HOXB4 proteins with improved stability, and methods of use thereof
10/18/2011	US8039435 Melanocortin receptor ligands
10/18/2011	US8039434 Method for producing human insulin-like growth factor I
10/18/2011	US8039433 Osteogenic compositions containing a coloring agent
10/18/2011	US8039432 Method of treatment of diabetes and/or obesity with reduced nausea side effect
10/18/2011	US8039431 Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10/18/2011	US8039430 Peptidic compounds
10/18/2011	US8039429 Method of treatment using high-affinity antagonists of ELR-CXC chemokines
10/18/2011	US8039259 Buffer solution for electroporation and a method comprising the use of the same
10/18/2011	US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011	US8039253 Contains erythropoietin, which protectively acts on survival of oligodendrocytes, which form myelin sheath, in cerebrovascular dementia typified by multiple sclerosis and Binswanger disease
10/18/2011	US8039240 RNA degrading polypeptides for use in prevention and treatment of arthritis, inflammation, restenosis, nervous system and cell proliferative diseases

1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 3163